BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34680535)

  • 1. The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth.
    Lobo J; Ohashi R; Helmchen BM; Rupp NJ; Rüschoff JH; Moch H
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
    Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H
    Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary renal cell carcinoma: current and controversial issues.
    Angori S; Lobo J; Moch H
    Curr Opin Urol; 2022 Jul; 32(4):344-351. PubMed ID: 35674688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
    Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
    Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.
    Srigley JR; Delahunt B; Eble JN; Egevad L; Epstein JI; Grignon D; Hes O; Moch H; Montironi R; Tickoo SK; Zhou M; Argani P;
    Am J Surg Pathol; 2013 Oct; 37(10):1469-89. PubMed ID: 24025519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features.
    Denize T; Just PA; Sibony M; Blons H; Timsit MO; Drossart T; Jakubowicz D; Broudin C; Morini A; Molina T; Vano Y; Auvray-Kuentz M; Richard S; Mejean A; Gimenez Roqueplo AP; Burnichon N; Verkarre V
    Mod Pathol; 2021 Mar; 34(3):647-659. PubMed ID: 32770124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Provisional renal cell carcinoma subsets following the 2016 WHO classification].
    Jenei A; Hes O; Kuthi L
    Orv Hetil; 2020 Jan; 161(3):83-94. PubMed ID: 31928058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
    Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
    Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IPSILATERAL SYNCHRONOUS MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA AND CLEAR CELL PAPILLARY RENAL CELL CARCINOMA: A CASE REPORT AND REVIEW OF THE LITERATURE].
    Tanigawa M; Huruuchi T; Tamura K; Nakajima F; Domoto H; Mukai K; Nagashima Y
    Nihon Hinyokika Gakkai Zasshi; 2020; 111(4):134-139. PubMed ID: 34670912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Williamson SR; Gill AJ; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Hes O
    Mod Pathol; 2021 Jun; 34(6):1167-1184. PubMed ID: 33526874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012].
    Hes O
    Cesk Patol; 2014; 50(4):137-41. PubMed ID: 25418900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma.
    Collins K; Hwang M; Antic T; Paintal A; Argani P; Matoso A; Gopinath A; Baskovich B; Mehra R; Williamson SR; Idrees MT; Barletta JA; Anderson WJ; Hirsch MS; Hornick JL; Acosta AM
    Histopathology; 2022 Nov; 81(5):577-586. PubMed ID: 35971742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights in the new WHO classification of adult renal tumors.
    Hes O; Michalová K; Pivovarčíková K
    Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: Evolving and emerging subtypes.
    Crumley SM; Divatia M; Truong L; Shen S; Ayala AG; Ro JY
    World J Clin Cases; 2013 Dec; 1(9):262-75. PubMed ID: 24364021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity.
    Wang XT; Xia QY; Fang R; Zhang RS; Ye SB; Li R; Wang X; Lu ZF; Ma HH; Zhou XJ; He HY; Zhao M; Rao Q
    Hum Pathol; 2022 May; 123():102-112. PubMed ID: 35192800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration.
    Chumbalkar V; Wang P; Paner GP
    Hum Pathol; 2022 Mar; 121():11-18. PubMed ID: 34929230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
    Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.